Chimagen Biosciences, Ltd
1 clinical trials · Sponsor
◉ Watch Chimagen Biosciences, Ltd
| Record | Firm | Date |
|---|---|---|
| First-in-Human (FIH) Trial of 1A46 in Subjects with Advanced CD20 And/or CD19 Positive B-cell Hematologic Malignancies (NCT05348889) | Chimagen Biosciences, Ltd | 2022-08-30 |
Track Chimagen Biosciences, Ltd automatically
Every clearance here is in the API, with alerts when new ones post.